Miami Cancer Institute Precision Oncology Symposium, Third Annual - Day 1

February 7, 2025
 

Live Symposium | 11 Cat. 1
Friday-Saturday, February 7-8, 2025
Loews Coral Gables Hotel, Coral Gables, Florida

Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors — including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors — by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Summarize the evolving therapeutic strategies in the treatment of solid tumor malignancies.
  • Provide an update of new molecular and targeted treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors.
  • Review the role and timing of diagnostic tests, molecular profiling and potential combinations of targeted therapy treatment options.

Who Should Attend

This educational program is directed toward oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, pharmacists, medical students, residents and fellows in training, research staff and other allied healthcare members interested in the treatment of patients with solid tumor malignancies.

 

Course Summary
Available credit: 
  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 General certificate of attendance
  • 7.00 Nurse Practitioners
  • 7.00 Florida Board of Nursing
  • 7.25 Florida Board of Pharmacy
  • 7.00 Florida Board of Respiratory Therapy
Course opens: 
02/04/2025
Course expires: 
02/28/2025
Event starts: 
02/07/2025 - 8:00am EST
Event ends: 
02/07/2025 - 5:00pm EST
Add to calendar: 
Loews Coral Gables Hotel
Coral Gables, FL
United States

Accreditation

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for a total of 11 credit hours, (Friday - 7.25 - CE Broker Course #20-1278495 and Saturday - 3.75 - CE Broker Course #20-1278499, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.

This activity is approved for 10.5 credit hours for Nurse Practitioners, Nurses and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.

This activity is approved for 11 credit hours for Pharmacists and Techs. Baptist Health South Florida CE Broker Provider #50-182.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Disclaimer

Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Available Credit

  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 General certificate of attendance
  • 7.00 Nurse Practitioners
  • 7.00 Florida Board of Nursing
  • 7.25 Florida Board of Pharmacy
  • 7.00 Florida Board of Respiratory Therapy
Please login or register for a Baptist Health CME account to take this course.